Zhang Chao, Hu Yun-Yu, Cui Fu-Zhai, Zhang Shu-Ming, Ruan Di-Ke
Department of Orthopaedics, Navy General Hospital of PLA, Beijing 100037, People's Republic of China.
Biomed Mater. 2006 Jun;1(2):56-62. doi: 10.1088/1748-6041/1/2/002. Epub 2006 Apr 6.
We investigated the in vivo osteogenic ability of rhBMP-2 induced periosteal cells in a new porous scaffold, nano-hydroxyapatite (nano-HA)/collagen/poly(L-lactic acid) (PLA). The nano-HA/collagen/PLA composites were utilized as an extracellular matrix for a cell-based strategy of bone tissue engineering. Periosteal cells were cultivated with 500 ng ml(-1) rhBMP-2, followed by seeding into prewet nano-HA/collagen/PLA scaffolds. The cell-scaffold constructs were then subcutaneously implanted in nude mice compared to controls with cell suspension and scaffold alone. Scanning electron microscopy examination proved that the scaffold supported adhesion and proliferation of periosteal cells. Histological bone formation was observed only in experimental groups with cell transplants 8 weeks post-implantation. The animals of the control groups did not show bone formation. The results strongly encourage the approach of the transplantation of rhBMP-2 induced periosteal cells within a suitable carrier structure for bone regeneration.
我们研究了重组人骨形态发生蛋白-2(rhBMP-2)诱导的骨膜细胞在新型多孔支架——纳米羟基磷灰石(nano-HA)/胶原蛋白/聚(L-乳酸)(PLA)中的体内成骨能力。纳米HA/胶原蛋白/PLA复合材料被用作基于细胞的骨组织工程策略的细胞外基质。骨膜细胞用500 ng/ml rhBMP-2培养,然后接种到预先湿润的纳米HA/胶原蛋白/PLA支架中。与单独的细胞悬液和支架对照组相比,将细胞-支架构建体皮下植入裸鼠体内。扫描电子显微镜检查证明该支架支持骨膜细胞的黏附和增殖。仅在植入后8周进行细胞移植的实验组中观察到组织学骨形成。对照组动物未显示骨形成。这些结果有力地支持了在合适的载体结构内移植rhBMP-2诱导的骨膜细胞以促进骨再生的方法。